LaNova Medicines
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
礼新医药宣布与阿斯利康就新型GPRC5D靶向抗体偶联药物LM-305达成全球独家授权协议 2023-05-12 23:30
1